- Home
- PBT vs EYPT Comparison
PBT vs EYPT Comparison
Compare PBT & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBT
- EYPT
- Stock Information
- Founded
- PBT 1980
- EYPT 1987
- Country
- PBT United States
- EYPT United States
- Employees
- PBT N/A
- EYPT N/A
- Industry
- PBT Oil & Gas Production
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- PBT Energy
- EYPT Industrials
- Exchange
- PBT Nasdaq
- EYPT Nasdaq
- Market Cap
- PBT 835.7M
- EYPT 741.0M
- IPO Year
- PBT N/A
- EYPT 2005
- Fundamental
- Price
- PBT $18.10
- EYPT $13.88
- Analyst Decision
- PBT
- EYPT Strong Buy
- Analyst Count
- PBT 0
- EYPT 6
- Target Price
- PBT N/A
- EYPT $25.83
- AVG Volume (30 Days)
- PBT 141.4K
- EYPT 807.9K
- Earning Date
- PBT 01-01-0001
- EYPT 11-06-2025
- Dividend Yield
- PBT 2.92%
- EYPT N/A
- EPS Growth
- PBT N/A
- EYPT N/A
- EPS
- PBT 0.35
- EYPT N/A
- Revenue
- PBT $18,413,820.00
- EYPT $51,898,000.00
- Revenue This Year
- PBT N/A
- EYPT N/A
- Revenue Next Year
- PBT N/A
- EYPT N/A
- P/E Ratio
- PBT $52.29
- EYPT N/A
- Revenue Growth
- PBT N/A
- EYPT 2.99
- 52 Week Low
- PBT $8.01
- EYPT $3.91
- 52 Week High
- PBT $18.80
- EYPT $14.42
- Technical
- Relative Strength Index (RSI)
- PBT 64.77
- EYPT 68.27
- Support Level
- PBT $17.61
- EYPT $12.88
- Resistance Level
- PBT $18.79
- EYPT $14.15
- Average True Range (ATR)
- PBT 0.65
- EYPT 0.76
- MACD
- PBT -0.05
- EYPT 0.03
- Stochastic Oscillator
- PBT 75.56
- EYPT 84.49
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.